Activation-induced cell death in T cells

被引:491
作者
Green, DR [1 ]
Droin, N [1 ]
Pinkoski, M [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA
关键词
D O I
10.1034/j.1600-065X.2003.00051.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A properly functioning immune system is dependent on programmed cell death at virtually every stage of lymphocyte development and activity. This review addresses the phenomenon of activation-induced cell death (AICD) in T lymphocytes, in which activation through the T-cell receptor results in apoptosis. AICD can occur in a cell-autonomous manner and is influenced by the nature of the initial T-cell activation events. It plays essential roles in both central and peripheral deletion events involved in tolerance and homeostasis, although it is likely that different forms of AICD proceed via different mechanisms. For example, while AICD in peripheral T cells is often caused by the induction of expression of the death ligand, Fas ligand (CD95 ligand, FasL), it does not appear to be involved in AICD in thymocytes. This and other mechanisms of AICD are discussed. One emerging model that may complement other forms of AICD involves the inducible expression of FasL by nonlymphoid tissues in response to activated T lymphocytes. Induction of nonlymphoid FasL in this manner may serve as a sensing mechanism for immune cell infiltration, which contributes to peripheral deletion.
引用
收藏
页码:70 / 81
页数:12
相关论文
共 121 条
  • [41] Jeremias I, 1998, EUR J IMMUNOL, V28, P143, DOI 10.1002/(SICI)1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO
  • [42] 2-3
  • [43] FAS(CD95) FASL INTERACTIONS REQUIRED FOR PROGRAMMED CELL-DEATH AFTER T-CELL ACTIVATION
    JU, ST
    PANKA, DJ
    CUI, HL
    ETTINGER, R
    ELKHATIB, M
    SHERR, DH
    STANGER, BZ
    MARSHAKROTHSTEIN, A
    [J]. NATURE, 1995, 373 (6513) : 444 - 448
  • [44] Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction
    Kang, SM
    Schneider, DB
    Lin, ZH
    Hanahan, D
    Dichek, DA
    Stock, PG
    Baekkeskov, S
    [J]. NATURE MEDICINE, 1997, 3 (07) : 738 - 743
  • [45] Fas ligand (CD95 ligand) controls angiogenesis beneath the retina
    Kaplan, HJ
    Leibole, MA
    Tezel, T
    Ferguson, TA
    [J]. NATURE MEDICINE, 1999, 5 (03) : 292 - 297
  • [46] A 'non-canonical' DNA-binding element mediates the response of the Fas-ligand promoter to c-Myc
    Kasibhatla, S
    Beere, HM
    Brunner, T
    Echeverri, F
    Green, DR
    [J]. CURRENT BIOLOGY, 2000, 10 (19) : 1205 - 1208
  • [47] DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-KB and AP-1
    Kasibhatla, S
    Brunner, T
    Genestier, L
    Echeverri, F
    Mahboubi, A
    Green, DR
    [J]. MOLECULAR CELL, 1998, 1 (04) : 543 - 551
  • [48] Regulation of Fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor κB
    Kasibhatla, S
    Genestier, L
    Green, DR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (02) : 987 - 992
  • [49] PROGRAMMED CELL-DEATH AND EXTRATHYMIC REDUCTION OF V-BETA-8+ CD4+ T-CELLS IN MICE TOLERANT TO STAPHYLOCOCCUS-AUREUS ENTEROTOXIN-B
    KAWABE, Y
    OCHI, A
    [J]. NATURE, 1991, 349 (6306) : 245 - 248
  • [50] VISUALIZATION OF PEPTIDE-SPECIFIC T-CELL IMMUNITY AND PERIPHERAL TOLERANCE INDUCTION IN-VIVO
    KEARNEY, ER
    PAPE, KA
    LOH, DY
    JENKINS, MK
    [J]. IMMUNITY, 1994, 1 (04) : 327 - 339